Current News

Omnilux on TV 11th Feb 2009

Role of Mast cell in wound healing and Skin rejuvenation elucidated 11th Feb 2009

Omnilux Clear-U™ Hand- Held device recieves FDA approval 16th January 2009

Omnilux New-U™ Hand-Held device recieves FDA approval 6th March 2008

Omnilux Plus receives TGA approval 6th March 2008

Photo Therapeutics Ltd appoint Sigmacon Medical Products 5th Dec 2007

Omnilux system honoured 11th November 2007

Omnilux Medical Bulletin Issue 7 9th October 2007

Clinical Study adds weight to LED Therapy 3rd August 2007 

Recent Photo Therapeutics webcast available to download 7th December 2006

Photo Therapeutics Ltd Publication list by indication 15th November 2006

Expand your product portfolio, Distributors wanted. 1st July 2006

Omnilux combination phototherapy receives FDA clearance 20th March 2005

Omnilux plus  receives FDA clearance 15th March 2005

Last Updated 11th February 2009

 

Registered in England No. 3475828      VAT No. GB719704226

Registered Office: Station House, Altrincham, Cheshire WA14 1EP

 © Photo Therapeutics  Ltd 2005 all rights reserved


Omnilux blueTM  for Acne and Actinic keratosis

Using the same platform as Omnilux PDTTM, Omnilux reviveTM and Omnilux plusTM ,Omnilux blueTM utilises the core technology developed by Photo Therapeutics Ltd and can be delivered from a standard medical base unit using the interchangeable treatment head.

Omnilux blueTM is based on a matrix of LEDs, which provide narrowband visible light. The individual LED cone angle and the spacing of the LEDs ensure uniformity of the beam for full coverage of the treatment area.

The high spectral purity also means that no UV, IR or inappropriate visible radiation is delivered, increasing both the precision and effectiveness of the treatment. Ten years of research regarding light sources for PDT ensures that all criteria for optimised efficacy of treatment are covered i.e. treatment time, intensity and wavelengths that activate relevant absorption spectra.

Omnilux blueTM has been specifically developed to target the naturally occurring photosensitiser, Coproporphyrin III, found in P.acnes bacteria.  Omnilux blueTM is the most potent blue light source in activating the target photosensitiser, producing singlet oxygen that leads to rapid eradication of the P.acnes bacteria. The output of Omnilux blueTM is also optimised to activate the photosenstiser 5-aminolaevulinic acid and is therefore ideally suited for the treatment of Actinic keratosis. Omnilux blueTM delivers 40mW/cm2 48J/ cm2 .

The clinician can control the area of illumination and can shape the light to the contour of the treatment area. Only this way can the entire treatment area receive the required dose of light for effective therapy.

The Omnilux blueTM unit showing the array of light emitting diodes


Specifications
Omnilux blue
TM

Total output power

20+/-5W

Output Intensity   

40mW/cm2

Output wavelength

415+/-5nm

Bandwidth

22nm+/-3nm

Standard Dose

48J/cm2

Treatment time (standard dose)

20 minutes

Dose range (adjustable)

1-55J/cm2

Lamp type

LED

Weight

12Kg

Unit dimensions (H x W x D)            

370/180/490 mm

Head dimensions overall (L x W)

315mm x 350mm

Dimensions of LED head active area. (L x W)

150mm x 350mm

Dimensions of single LED area. (L x W)

75mm x 70mm